Not known Factual Statements About phenobarbital sodium drug class
Not known Factual Statements About phenobarbital sodium drug class
Blog Article
pentobarbital will lessen the extent or effect of erlotinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will reduce the level or effect of ibuprofen by affecting hepatic enzyme CYP2C9/ten metabolism. Minor/Significance Mysterious.
Contraindicated (1)pentobarbital will lessen the extent or effect of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is a delicate CYP3A4 substrate. Coadministration with potent or average CYP3A4 inducers is contraindicated.
pentobarbital will lessen the extent or effect of diltiazem by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will reduce the level or effect of midostaurin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Strong CYP3A4 inducers might minimize midostaurin concentrations causing lessened efficacy.
“On the other hand, the federal government does guide by example and also to hold the federal government so sharply likely using this method is deeply troubling.”
Specific affected individual populace: Dosage needs to be minimized in the aged or debilitated since these sufferers may very well be more delicate to barbiturates. Dosage ought to be decreased for individuals with impaired renal function or hepatic disorder.
Observe Carefully (one)pentobarbital will lessen the extent or effect of fentanyl transmucosal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Closely. Coadministration of fentanyl with CYP3A4 inducers could lead to some reduce in fentanyl plasma concentrations, insufficient efficacy or, probably, development of the withdrawal syndrome inside of a affected individual who may have created physical dependence to fentanyl. After halting a CYP3A4 inducer, since the effects on the inducer drop, the fentanyl plasma concentration will raise which could enhance or prolong both of those the therapeutic and adverse effects.
Doxycycline: Phenobarbital has been shown to shorten the half-life of doxycycline for website as long as 2 months after barbiturate therapy is discontinued.
pentobarbital will decrease the extent or effect of solifenacin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
Sodium valproate and valproic acid surface to reduce barbiturate metabolism; for that reason, barbiturate blood levels must be monitored and correct dosage adjustments created as indicated.
pentobarbital will reduce the extent or effect of bosentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.
pentobarbital will decrease the level or effect of tolterodine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will lower the extent or effect of clozapine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.